Home > Boards > US Listed > Biotechs > FLEX Pharma (FLKS)

Why is this even breaking out?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
HeadHunter Member Profile
 
Followed By 30
Posts 1,430
Boards Moderated 1
Alias Born 07/25/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 5:26:05 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 6/14/2019 5:24:05 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 6/10/2019 4:17:16 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 6/10/2019 10:21:20 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 6/6/2019 10:01:16 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/31/2019 7:01:49 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/28/2019 10:32:15 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/22/2019 3:13:03 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/20/2019 6:02:03 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/17/2019 9:54:53 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/16/2019 10:40:23 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/10/2019 5:31:21 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 5/10/2019 5:30:59 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/1/2019 4:18:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2019 7:33:52 AM
Flex Pharma Reports First Quarter 2019 Financial Results Business Wire - 5/1/2019 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/30/2019 6:12:40 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/29/2019 3:23:31 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/24/2019 4:16:28 PM
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) Edgar (US Regulatory) - 4/18/2019 6:01:58 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/16/2019 4:13:33 PM
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) Edgar (US Regulatory) - 3/26/2019 6:06:35 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/6/2019 5:09:07 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/6/2019 4:14:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2019 7:27:51 AM
HeadHunter   Friday, 04/12/19 07:06:37 PM
Re: AugustaFriends post# 139
Post # of 162 
Why is this even breaking out?

I can not find much on OTCMarkets.

Just intrigued by the move today and into post market.

Flex Pharma, Inc. (FLKS)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of FLKS to Salarius Pharmaceuticals, LLC.

If you are a FLKS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.


Thanks in Advance!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist